Abstract:Background Adenine base editors (ABEs) are promising therapeutic gene editing tools that can efficiently convert targeted A•T to G•C base pairs in the genome. However, the large size of commonly used ABEs based on SpCas9 hinders its delivery in vivo using certain vectors such as adeno-associated virus (AAV) during preclinical applications. Despite a number of approaches having previously been attempted to overcome that challenge, including split Cas9-derived and numerous domain-deleted versions of editors, whether base editor (BE) and prime editor (PE) systems can also allow deletion of those domains remains to be proven. In this study, we present a new small ABE (sABE) with significantly reduced size. Results We discovered that ABE8e can tolerate large single deletions in the REC2 (Δ174-296) and HNH (Δ786-855) domains of SpCas9, and these deletions can be stacked together to create a new sABE. The sABE showed higher precision than the original ABE8e, with proximally shifted protospacer adjacent motif (PAM) editing windows (A3- A15), and comparable editing efficiencies to 8e-SaCas9-KKH. The sABE system efficiently generated A-G mutations at disease-relevant loci (T1214C in GAA and A494G in MFN2 ) in HEK293T cells and several canonical Pcsk9 splice sites in N2a cells. Moreover, the sABE enabled in vivo delivery in a single adeno-associated virus (AAV) vector with slight efficiency. Furthermore, we also successfully edited the genome of mouse embryos by microinjecting mRNA and sgRNA of sABE system into zygotes. Conclusions We have developed a substantially smaller sABE system that expands the targeting scope and offers higher precision of genome editing. Our findings suggest that the sABE system holds great therapeutic potential in preclinical applications.

An APOBEC3A-Cas9 Base Editor with Minimized Bystander and Off-Target Activities

Precise base editing with CC context-specificity using engineered human APOBEC3G-nCas9 fusions

Engineering APOBEC3A deaminase for highly accurate and efficient base editing

Engineering precise adenine base editor with infinitesimal rates of bystander mutations and off-target editing

Eliminating Base-Editor-induced Genome-Wide and Transcriptome-Wide Off-Target Mutations

Expanding the Genome-Targeting Scope and the Site Selectivity of High-Precision Base Editors

Single C-to-T substitution using engineered APOBEC3G-nCas9 base editors with minimum genome- and transcriptome-wide off-target effects

Engineering a Precise Adenine Base Editor with Minimal Bystander Editing.

Cas12a Base Editors Induce Efficient and Specific Editing with Low DNA Damage Response

Transcriptome-wide off-target RNA editing induced by CRISPR-guided DNA base editors

Cas9-orthologue-mediated cytosine and adenine base editors recognizing NNAAAA PAM sequences

TadA reprogramming to generate potent miniature base editors with high precision

Base Editing with a Cpf1–cytidine Deaminase Fusion

A Novel Base Editor SpRY-ABE8eF148A Mediates Efficient A-to-G Base Editing with a Reduced Off-Target Effect

AcrIIA5 Suppresses Base Editors and Reduces Their Off-Target Effects

A New Compact Adenine Base Editor Generated Through Deletion of HNH and REC2 Domain of SpCas9

Harnessing A3G for efficient and selective C-to-T conversion at C-rich sequences

Increasing the Efficiency and Targeting Range of Cytidine Base Editors Through Fusion of a Single-Stranded DNA-binding Protein Domain

Re-engineering the adenine deaminase TadA-8e for efficient and specific CRISPR-based cytosine base editing

Glycosylase-based Base Editors for Efficient T-to-G and C-to-G Editing in Mammalian Cells

Efficient base editing in methylated regions with a human APOBEC3A-Cas9 fusion